Christine Sternstein and a team at the University of Wuerzburg synthesized a new azido-functionalized S1P derivative that can be labeled via click chemistry with alkyne-substituted molecules.

Louise Kersting was awarded a poster prize at a renowned international seminar in Klosters (Switzerland).

Completely unexpectedly, the enzyme ceramidase emerges as a new target structure for the therapy of SARS-CoV-2 infections. This is reported by Würzburg researchers in "Cells".